info icon

Diabetes, insulin treatment (Kela reimbursement)

KELA_DIAB_INSUL

No definition available.

Endpoint definition

FinnGen phenotype data

414262 individuals

diagram downward connector

Apply sex-specific rule None

414262

diagram downward connector

Check conditions None

414262

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

KELA reimbursements: KELA codes 103

1 out of 7 registries used, show all original rules.

60949

diagram downward connector

Check minimum number of events None

60949

diagram downward connector

Include endpoints None

60949

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

53892

diagram downward connector
KELA_DIAB_INSUL

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to Diabetes, insulin treatment (Kela reimbursement) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 53892 23349 30543
Unadjusted prevalence (%) 14.29 11.08 18.37
Mean age at first event (years) 54.88 53.69 55.78

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: KELA_DIAB_INSUL – Diabetes, insulin treatment (Kela reimbursement)
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Diabetes, insulin treatment (Kela reimbursement)

Endpoint not on priority list, no data to show.